Amarin Corporation plc (AMRN)

$14.84

up-down-arrow $-0.06 (-0.40%)

As on 07-May-2026 16:00EDT

Market cap

info icon

$312 Mln

Revenue (TTM)

info icon

$215 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Amarin (AMRN) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 14.54 High: 14.92

52 Week Range

Low: 9.44 High: 20.90

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -0.1 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -5.8

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-1.6

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    20,969,109

10 Years Aggregate

CFO

$-627.25 Mln

EBITDA

$-519.79 Mln

Net Profit

$-640.29 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Amarin (AMRN)
6.3 1.4 5.3 45.6 -18.9 -30.4 -6.9
BSE Sensex*
-8.7 3.6 -7.5 -4.2 8.2 9.5 11.9
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 07-May-2026  |  *As on 08-May-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
Amarin (AMRN)
43.9 -44.0 -28.1 -64.1 -31.1 -77.2 57.5
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Amarin (AMRN)
14.8 312.4 214.9 -33.6 -2.4 -7.4 -- 0.7
27.5 1,604.5 66.1 -422.6 -720.0 -35.3 -- 0.7
7.0 1,753.9 427.7 -58.1 -9.0 -38.3 -- 12.2
21.4 1,082.3 412.8 -8.2 -2.6 -2.6 -- 3.5
14.1 908.8 0.0 -69.7 -- -33.4 -- 3.8
84.6 7,095.5 51.5 -315.1 -477.7 -25.3 -- 4.5
428.7 12,189.0 2,678.3 460.4 21.1 103.2 26.9 19.9
12.2 1,010.5 204.9 -157.3 -39.6 -- -- 25.4
20.5 1,829.8 217.2 -243.3 -31.2 -309.8 -- 42.5
31.6 3,747.9 0.0 -472.3 -- -77.8 -- 7.3

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Amarin (AMRN)

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only...  omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Address: One Central Plaza, Dublin, Ireland, D02 K7K5  Read more

  • President, CEO & Director

    Mr. Patrick J. Holt

  • President, CEO & Director

    Mr. Patrick J. Holt

  • Headquarters

    Dublin

  • Website

    https://www.amarincorp.com

Edit peer-selector-edit
loading...
loading...

FAQs for Amarin (AMRN)

The share price of Amarin Corporation plc (AMRN) is $14.84 (NASDAQ) as of 07-May-2026 16:00 EDT. Amarin Corporation plc (AMRN) has given a return of -18.88% in the last 3 years.

Since, TTM earnings of Amarin Corporation plc (AMRN) is negative, P/E ratio is not available.
The P/B ratio of Amarin Corporation plc (AMRN) is 0.67 times as on 07-May-2026, a 85 discount to its peers’ median range of 4.45 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-7.48
0.63
2024
-0.12
0.02
2023
-0.30
0.03
2022
-0.23
0.04
2021
8.76
0.10

The 52-week high and low of Amarin Corporation plc (AMRN) are Rs 20.90 and Rs 9.44 as of 08-May-2026.

Amarin Corporation plc (AMRN) has a market capitalisation of $ 312 Mln as on 07-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Amarin Corporation plc (AMRN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.